Azenta, Inc. (NASDAQ:AZTA) Shares Purchased by Schroder Investment Management Group

Schroder Investment Management Group boosted its position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 46.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,405,056 shares of the company's stock after purchasing an additional 447,292 shares during the quarter. Schroder Investment Management Group owned about 3.08% of Azenta worth $70,183,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of AZTA. Ballentine Partners LLC raised its holdings in shares of Azenta by 2.0% in the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company's stock valued at $1,017,000 after purchasing an additional 404 shares in the last quarter. Picton Mahoney Asset Management raised its stake in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company's stock worth $35,000 after buying an additional 532 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Azenta by 14.9% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,446 shares of the company's stock worth $225,000 after buying an additional 576 shares during the period. Glenmede Trust Co. NA boosted its position in Azenta by 6.3% during the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock valued at $551,000 after acquiring an additional 679 shares in the last quarter. Finally, KBC Group NV increased its holdings in shares of Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock valued at $107,000 after acquiring an additional 698 shares during the period. 99.08% of the stock is owned by institutional investors.

Remove Ads

Azenta Price Performance

Azenta stock traded down $2.18 during midday trading on Friday, reaching $29.12. The company's stock had a trading volume of 1,065,606 shares, compared to its average volume of 614,695. The stock has a market capitalization of $1.33 billion, a P/E ratio of -9.77 and a beta of 1.66. The stock's 50-day simple moving average is $43.01 and its 200-day simple moving average is $45.75. Azenta, Inc. has a 52-week low of $27.93 and a 52-week high of $63.58.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities research analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. TD Cowen raised Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC increased their price target on shares of Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research report on Thursday, February 6th. Stephens reaffirmed an "overweight" rating and issued a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Finally, Evercore ISI increased their target price on shares of Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research report on Thursday, February 6th.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.